Jonas de Souza, MD

Articles by Jonas de Souza, MD

Using Clinically Nuanced Cost Sharing to Enhance Consumer Access to Specialty Medications

ByJason Buxbaum, MHSA,Jonas de Souza, MD,A. Mark Fendrick, MD

June 27th 2014

In conjunction with provider-oriented payment reform, tools like VBID that change the focus from how much to how well we spend our healthcare dollars.

Putting Value Into Practice

ByA. Mark Fendrick, MD,Jonas de Souza, MD

March 12th 2012

Insights Into Value-Based Insurance Design in Oncology

Latest Updated Articles

Putting Value Into Practice
March 12th 2012
Using Clinically Nuanced Cost Sharing to Enhance Consumer Access to Specialty Medications
June 27th 2014

Jonas de Souza, MD

Articles by Jonas de Souza, MD

Using Clinically Nuanced Cost Sharing to Enhance Consumer Access to Specialty Medications

Putting Value Into Practice

Latest Updated Articles

Trending on AJMC

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Social Factors May Match, Outpace Genetic Risk in Disease Prediction

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC

Switch to Ocrelizumab Shows Safety in Patients With Relapsing MS

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Jonas de Souza, MD

Articles by Jonas de Souza, MD

Using Clinically Nuanced Cost Sharing to Enhance Consumer Access to Specialty Medications

Putting Value Into Practice

Latest Updated Articles

Trending on AJMC

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Social Factors May Match, Outpace Genetic Risk in Disease Prediction

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC

Switch to Ocrelizumab Shows Safety in Patients With Relapsing MS